Microrna-101b Attenuates Cardiomyocyte Hypertrophy By Inhibiting Protein Kinase C Epsilon Signaling
FEBS LETTERS(2017)
摘要
Previously, a surgical regression model identified microRNA-101b (miR-101b) as a potential inhibitor of cardiac hypertrophy. Here, we investigated the antihypertrophic mechanism of miR-101b using neonatal rat ventricular myocytes. miR-101b markedly suppressed agonist-induced cardiac hypertrophy as shown by cell size and fetal gene expression. By systems biology approaches, we identified protein kinase C epsilon (PKC epsilon) as the major target of miR-101b. Our results from qRT-PCR, western blot, and luciferase reporter assays confirm that PKC epsilon is a direct target of miR-101b. In addition, we found that effectors downstream of PKCe (p-AKT, p-ERK1/2, p-NFAT, and p-GSK3 beta) are also affected by miR-101b. Our study reveals a novel inhibitory mechanism for miR-101b as a negative regulator of cardiac hypertrophy.
更多查看译文
关键词
cardiomyocytes,miR-101b,microRNA,myocardial hypertrophy,protein kinase C,systems biology
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要